Michael D. Burkitt

2.1k total citations
33 papers, 1.5k citations indexed

About

Michael D. Burkitt is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, Michael D. Burkitt has authored 33 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 9 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Michael D. Burkitt's work include Helicobacter pylori-related gastroenterology studies (15 papers), Inflammatory Bowel Disease (6 papers) and Gut microbiota and health (6 papers). Michael D. Burkitt is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (15 papers), Inflammatory Bowel Disease (6 papers) and Gut microbiota and health (6 papers). Michael D. Burkitt collaborates with scholars based in United Kingdom, Australia and Ireland. Michael D. Burkitt's co-authors include D. Mark Pritchard, Carrie A. Duckworth, Jonathan Williams, Barry J. Campbell, Alastair J.M. Watson, Andrea Varró, Marek Gawel, F. Clifford Rose, Jorge Caamaño and Chris Probert and has published in prestigious journals such as PLoS ONE, Oncogene and Gut.

In The Last Decade

Michael D. Burkitt

33 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael D. Burkitt United Kingdom 19 485 479 276 220 206 33 1.5k
Ping Zheng China 27 612 1.3× 438 0.9× 268 1.0× 155 0.7× 202 1.0× 102 1.8k
Christian Barmeyer Germany 20 845 1.7× 417 0.9× 224 0.8× 213 1.0× 198 1.0× 28 1.7k
Vasantha L. Kolachala United States 20 505 1.0× 360 0.8× 164 0.6× 220 1.0× 371 1.8× 43 1.7k
Amy C. Engevik United States 25 884 1.8× 661 1.4× 390 1.4× 87 0.4× 318 1.5× 62 2.0k
Le Liu China 18 883 1.8× 253 0.5× 130 0.5× 211 1.0× 205 1.0× 52 1.6k
Eva Rath Germany 23 979 2.0× 317 0.7× 274 1.0× 284 1.3× 437 2.1× 42 2.2k
Jun Kato Japan 21 404 0.8× 264 0.6× 639 2.3× 344 1.6× 169 0.8× 148 2.2k
Shoji Mitsufuji Japan 23 446 0.9× 732 1.5× 370 1.3× 84 0.4× 206 1.0× 82 1.7k
Sophie Fillon United States 26 812 1.7× 620 1.3× 120 0.4× 232 1.1× 472 2.3× 41 2.0k
Chikako Watanabe Japan 23 350 0.7× 338 0.7× 158 0.6× 249 1.1× 302 1.5× 72 1.3k

Countries citing papers authored by Michael D. Burkitt

Since Specialization
Citations

This map shows the geographic impact of Michael D. Burkitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Burkitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Burkitt more than expected).

Fields of papers citing papers by Michael D. Burkitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Burkitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Burkitt. The network helps show where Michael D. Burkitt may publish in the future.

Co-authorship network of co-authors of Michael D. Burkitt

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Burkitt. A scholar is included among the top collaborators of Michael D. Burkitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Burkitt. Michael D. Burkitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burkitt, Michael D., Carrie A. Duckworth, Georgina L. Hold, et al.. (2021). Long-Term Iron Deficiency and Dietary Iron Excess Exacerbate Acute Dextran Sodium Sulphate-Induced Colitis and Are Associated with Significant Dysbiosis. International Journal of Molecular Sciences. 22(7). 3646–3646. 18 indexed citations
2.
Frau, Alessandra, Umer Zeeshan Ijaz, Daisy Jonkers, et al.. (2021). Inter-kingdom relationships in Crohn’s disease explored using a multi-omics approach. Gut Microbes. 13(1). 1930871–1930871. 21 indexed citations
3.
Papoutsopoulou, Stamatia, Emily Smith, Philip Stegmaier, et al.. (2020). Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease. Disease Models & Mechanisms. 13(11). 11 indexed citations
4.
Parsons, Bryony N., Michael D. Burkitt, Andrew R. Moore, et al.. (2020). Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors. Cellular and Molecular Gastroenterology and Hepatology. 10(1). 113–132. 12 indexed citations
5.
Caamaño, Jorge, Michael D. Burkitt, Fábio Miyajima, et al.. (2019). NF-κB2 signalling in enteroids modulates enterocyte responses to secreted factors from bone marrow-derived dendritic cells. Cell Death and Disease. 10(12). 896–896. 25 indexed citations
6.
Frau, Alessandra, John Kenny, Luca Lenzi, et al.. (2019). DNA extraction and amplicon production strategies deeply inf luence the outcome of gut mycobiome studies. Scientific Reports. 9(1). 9328–9328. 52 indexed citations
7.
Papoutsopoulou, Stamatia, Michael D. Burkitt, François Bergey, et al.. (2019). Macrophage-Specific NF-κB Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients. Frontiers in Immunology. 10. 2168–2168. 36 indexed citations
8.
Williams, Jonathan, Nicholas Ellaby, Carrie A. Duckworth, et al.. (2018). Oral iron exacerbates colitis and influences the intestinal microbiome. PLoS ONE. 13(10). e0202460–e0202460. 71 indexed citations
9.
Parsons, Bryony N., Umer Zeeshan Ijaz, R. D'Amore, et al.. (2017). Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use. PLoS Pathogens. 13(11). e1006653–e1006653. 155 indexed citations
10.
Bond, Ashley, Michael D. Burkitt, Trevor F. Cox, et al.. (2017). Dual-focus magnification, high-definition endoscopy improves pathology detection in direct-to-test diagnostic upper gastrointestinal endoscopy. Journal of Gastrointestinal and Liver Diseases. 26(1). 19–24. 10 indexed citations
11.
Burkitt, Michael D., et al.. (2017). Mice lacking NF-κB1 exhibit marked DNA damage responses and more severe gastric pathology in response to intraperitoneal tamoxifen administration. Cell Death and Disease. 8(7). e2939–e2939. 7 indexed citations
12.
Miyajima, Fábio, et al.. (2017). Hexane Extracts of Calophyllum brasiliense Inhibit the Development of Gastric Preneoplasia in Helicobacter felis Infected INS-Gas Mice. Frontiers in Pharmacology. 8. 92–92. 8 indexed citations
13.
Bond, Ashley, et al.. (2016). Correlation between Faecal Tumour M2 Pyruvate Kinase and Colonoscopy for the Detection of Adenomatous Neoplasia in a Secondary Care Cohort. Journal of Gastrointestinal and Liver Diseases. 25(1). 71–77. 3 indexed citations
14.
Duckworth, Carrie A., et al.. (2015). bak deletion stimulates gastric epithelial proliferation and enhancesHelicobacter felis-induced gastric atrophy and dysplasia in mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 309(6). G420–G430. 3 indexed citations
15.
16.
Burkitt, Michael D., Jonathan Williams, Carrie A. Duckworth, et al.. (2013). Signaling mediated by the NF-κB sub-units NF-κB1, NF-κB2 and c-Rel differentially regulate Helicobacter felis-induced gastric carcinogenesis in C57BL/6 mice. Oncogene. 32(50). 5563–5573. 32 indexed citations
17.
18.
Davies, Jane C., Michael D. Burkitt, & Alastair J.M. Watson. (2009). Ascending cholangitis presenting with Lactococcus lactis cremoris bacteraemia: a case report. Journal of Medical Case Reports. 3(1). 3–3. 18 indexed citations
19.
Burkitt, Michael D., et al.. (2007). Potentiation of chemotherapeutics by the Hsp90 antagonist geldanamycin requires a steady serum condition. Molecular Carcinogenesis. 46(6). 466–475. 8 indexed citations
20.
Gawel, Marek, Vivette Glover, Michael D. Burkitt, M. Sandler, & F. Clifford Rose. (1981). The specific activity of platelet monoamine oxidase varies with platelet count during severe exercise and noradrenaline infusion. Psychopharmacology. 72(3). 275–277. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ping Zheng Breakdown of academic impact, for papers by Christian Barmeyer Breakdown of academic impact, for papers by Vasantha L. Kolachala Breakdown of academic impact, for papers by Amy C. Engevik Breakdown of academic impact, for papers by Le Liu Breakdown of academic impact, for papers by Eva Rath Breakdown of academic impact, for papers by Jun Kato Breakdown of academic impact, for papers by Shoji Mitsufuji Breakdown of academic impact, for papers by Sophie Fillon Breakdown of academic impact, for papers by Chikako Watanabe
Rankless by CCL
2026